Literature DB >> 10690409

Mechanisms of mRNA surveillance in eukaryotes.

P Hilleren1, R Parker.   

Abstract

A conserved mRNA degradation system, referred to as mRNA surveillance, exists in eukaryotic cells to degrade aberrant mRNAs. A defining aspect of aberrant transcripts is that the spatial relationship between the termination codon and specific downstream sequence information has been altered. A key, yet unknown, feature of the mRNA surveillance system is how this spatial relationship is assessed in individual transcripts. Two views have emerged to describe how discrimination between proper and improper termination might occur. In the first view, a surveillance complex assembles onto the mRNA after translation termination, and scans the mRNA in a 3' to 5' direction for a limited distance. If specific downstream sequence information is encountered during this scanning, then the surveillance complex targets the transcript for rapid decay. An alternate view suggests that the downstream sequence information influences how translation termination occurs. This view encompasses several ideas including: (a) The architecture of the mRNP can alter the rate of key steps in translation termination; (b) the discrimination between a proper and improper termination occurs via an internal, Upf1-dependent, timing mechanism; and (c) proper termination results in the restructuring of the mRNP to a form that promotes mRNA stability. This proposed model for mRNA surveillance is similar to other systems of kinetic proofreading that monitor the accuracy of other biogenic processes such as translation and spliceosome assembly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690409     DOI: 10.1146/annurev.genet.33.1.229

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  74 in total

1.  Splicing and 3' end formation in the definition of nonsense-mediated decay-competent human beta-globin mRNPs.

Authors:  G Neu-Yilik; N H Gehring; R Thermann; U Frede; M W Hentze; A E Kulozik
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  A cis-acting element known to block 3' mRNA degradation enhances expression of polyA-minus mRNA in wild-type yeast cells and phenocopies a ski mutant.

Authors:  J T Brown; A W Johnson
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

3.  RNA quality control: degradation of defective transfer RNA.

Authors:  Zhongwei Li; Stephan Reimers; Shilpa Pandit; Murray P Deutscher
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

4.  Complex regulation of the human gene for the Z-DNA binding protein DLM-1.

Authors:  Stefan Rothenburg; Thomas Schwartz; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

5.  Computational modeling of eukaryotic mRNA turnover.

Authors:  D Cao; R Parker
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

6.  Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay.

Authors:  Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  Defects in the mRNA export factors Rat7p, Gle1p, Mex67p, and Rat8p cause hyperadenylation during 3'-end formation of nascent transcripts.

Authors:  P Hilleren; R Parker
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

8.  Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts.

Authors:  N Zhang; X Zhang; C Peterson; L Li; R Legerski
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

9.  Identification of mRNA decapping activities and an ARE-regulated 3' to 5' exonuclease activity in trypanosome extracts.

Authors:  Joseph Milone; Jeffrey Wilusz; Vivian Bellofatto
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

10.  Analysis of the products of mRNA decapping and 3'-to-5' decay by denaturing gel electrophoresis.

Authors:  Naomi Bergman; Mateusz Opyrchal; Elizabeth J Bates; Jeffrey Wilusz
Journal:  RNA       Date:  2002-07       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.